These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CD24 targeting bi-specific antibody that simultaneously stimulates NKG2D enhances the efficacy of cancer immunotherapy. Han Y; Sun F; Zhang X; Wang T; Jiang J; Cai J; Gao Q; Hezam K; Liu Y; Xie J; Wang M; Zhang J J Cancer Res Clin Oncol; 2019 May; 145(5):1179-1190. PubMed ID: 30778749 [TBL] [Abstract][Full Text] [Related]
4. N-cadherin protects oral cancer cells from NK cell killing in the circulation by inducing NK cell functional exhaustion via the KLRG1 receptor. Lou C; Wu K; Shi J; Dai Z; Xu Q J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36096526 [TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells with metastasis-initiating competence survive fluid shear stress during hematogenous dissemination through CXCR4-PI3K/AKT signaling. Xin Y; Hu B; Li K; Hu G; Zhang C; Chen X; Tang K; Du P; Tan Y Cancer Lett; 2024 May; 590():216870. PubMed ID: 38614386 [TBL] [Abstract][Full Text] [Related]
6. NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal Carcinoma. Wang T; Sun F; Wang Y; Jiang J; Pan M; Yuan M; Zhang H; Du X; Hezam K; Song K; Wang M; Zhang J J Immunother; 2018 Apr; 41(3):109-117. PubMed ID: 29528990 [TBL] [Abstract][Full Text] [Related]
7. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388 [TBL] [Abstract][Full Text] [Related]
8. Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D. Sayitoglu EC; Georgoudaki AM; Chrobok M; Ozkazanc D; Josey BJ; Arif M; Kusser K; Hartman M; Chinn TM; Potens R; Pamukcu C; Krueger R; Zhang C; Mardinoglu A; Alici E; Temple HT; Sutlu T; Duru AD Front Immunol; 2020; 11():40. PubMed ID: 32082316 [TBL] [Abstract][Full Text] [Related]
9. MICA immune complex formed with alpha 3 domain-specific antibody activates human NK cells in a Fc-dependent manner. Du C; Bevers J; Cook R; Lombana TN; Rajasekaran K; Matsumoto M; Spiess C; Kim JM; Ye Z J Immunother Cancer; 2019 Aug; 7(1):207. PubMed ID: 31387641 [TBL] [Abstract][Full Text] [Related]
11. An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma. Mantovani S; Varchetta S; Mele D; Donadon M; Torzilli G; Soldani C; Franceschini B; Porta C; Chiellino S; Pedrazzoli P; Santambrogio R; Barabino M; Cigala C; Piccolo G; Opocher E; Maestri M; Sangiovanni A; Bernuzzi S; Lhospice F; Kraiem M; Mondelli MU; Oliviero B Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266137 [TBL] [Abstract][Full Text] [Related]
12. Fluid Shear Stress Sensitizes Cancer Cells to Receptor-Mediated Apoptosis via Trimeric Death Receptors. Mitchell MJ; King MR New J Phys; 2013 Jan; 15():015008. PubMed ID: 25110459 [TBL] [Abstract][Full Text] [Related]
13. Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. Liu X; Song J; Zhang H; Liu X; Zuo F; Zhao Y; Zhao Y; Yin X; Guo X; Wu X; Zhang H; Xu J; Hu J; Jing J; Ma X; Shi H Cancer Cell; 2023 Feb; 41(2):272-287.e9. PubMed ID: 36706761 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity. Min D; Lv XB; Wang X; Zhang B; Meng W; Yu F; Hu H Br J Cancer; 2013 Aug; 109(3):723-30. PubMed ID: 23820258 [TBL] [Abstract][Full Text] [Related]
15. The effect of mifepristone on the peripheral blood natural killer cell's cytotoxicity and expression of CD94/NKG2A and NKG2D during the implantation phase. Chen XY; Zhuang YL; Li L; Zhang WW; Huang LL Fertil Steril; 2010 May; 93(8):2615-20. PubMed ID: 19880106 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay. Abruzzese MP; Bilotta MT; Fionda C; Zingoni A; Soriani A; Vulpis E; Borrelli C; Zitti B; Petrucci MT; Ricciardi MR; Molfetta R; Paolini R; Santoni A; Cippitelli M J Hematol Oncol; 2016 Dec; 9(1):134. PubMed ID: 27903272 [TBL] [Abstract][Full Text] [Related]
17. Platelets impair natural killer cell reactivity and function in endometriosis through multiple mechanisms. Du Y; Liu X; Guo SW Hum Reprod; 2017 Apr; 32(4):794-810. PubMed ID: 28184445 [TBL] [Abstract][Full Text] [Related]
18. In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients. Konjević G; Mirjačić Martinović K; Vuletić A; Babović N Melanoma Res; 2010 Dec; 20(6):459-67. PubMed ID: 20938360 [TBL] [Abstract][Full Text] [Related]
19. NKG2D ligands expression and NKG2D-mediated NK activity in Sezary patients. Dulphy N; Berrou J; Campillo JA; Bagot M; Bensussan A; Toubert A J Invest Dermatol; 2009 Feb; 129(2):359-64. PubMed ID: 18754036 [TBL] [Abstract][Full Text] [Related]
20. Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway. Wu HY; Li KX; Pan WY; Guo MQ; Qiu DZ; He YJ; Li YH; Huang YX Int Immunopharmacol; 2022 Mar; 104():108497. PubMed ID: 34999394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]